- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02162927
Dietary Nitrate Supplementation and Crossfit Athletes
The Effects of Six-day Dietary Nitrate Supplementation on Strength and Endurance Measurements in Male CrossFit Athletes
In the past, dietary nitrate supplementation has been shown to have clinical benefits in the treatment of cardiovascular issues. More recently, however, the focus of nitrate supplementation has shifted to focus of human performance, and has shown to increase the time to exhaustion during maximal intensity exercise and lower the cost of oxygen consumption during submaximal intensity exercise. Acutely, nitrate supplementation in the form of beetroot juice has been shown to increase strength measurements, as well as increase the time to complete a 2000 meter rowing ergometer test. However, to the author's knowledge, there are no studies that link the relationship between multi-day nitrate supplementation and the rowing test or the nitrate's effect on strength when in the salt form. Additionally, to the author's knowledge, no evidence has been published which relates dietary nitrate supplementation and its effects on a CrossFit circuit workout.
Our central hypothesis is that six days of dietary nitrate supplementation will improve strength, endurance, a power more than a placebo in male CrossFit athletes.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The purpose of this randomized, double-blind, crossover study is to identify if dietary nitrate supplementation improves strength , endurance, and power measurements in male CrossFit athletes. Specifically, the strength measurements will be taken using isometric and isokinetic tests on the Biodex dynamometer. Endurance will be measured using time trials for a 2000 meter rowing test and the "Fran" CrossFit workout. Finally, power will be analyzed using the Wingate cycle test.
The treatment group will receive 1 serving of f potassium nitrate KNO3- (N) (8 mmols NO3-). The placebo group will receive 1 serving of the nitrate-free placebo (PL) potassium chloride (8 mmol KCl).
The participants will complete two three-day baseline testing, with a six-day supplementation period following each round of baseline testing. Following the first six-day supplementation period, there will be a 10 day washout period before the second baseline testing begins.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Florida
-
Tallahassee, Florida, United States, 32301
- CrossFit Blackbox
-
Tallahassee, Florida, United States
- Florida State University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- College-aged male CrossFit between the ages of 20 and 35 years (yr), a peak maximum oxygen uptake (VO2peak) of at least 50 ml/kg/min will be recruited to participate in this study.
Exclusion Criteria:
- Having any thyroid and/or kidney diseases that could affect NO synthesis and/or metabolism, any illness, smoking, taking other medications, injured, not well-trained (as noted by the VO2peak), consuming any other supplements at the time of the study except protein or multivitamin, allergic to any component of the supplement, including tree nuts, in case of potential packaging mixing and contamination. Women and children as well are excluded.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Potassium Nitrate (N)
This involves 1 serving (2 pills) of potassium nitrate KNO3- (N) (8 mmols NO3-).
The supplementation period is six days.
This pill must be taken on an empty stomach (2-3 hours after eating) and must be taken about 2-3 hours before exercise.
|
This pill must be taken on an empty stomach (2-3 hours after eating) and must be taken about 2-3 hours before exercise.
|
|
Placebo Comparator: Potassium Chloride
This involves 1 serving (2 pills) of the nitrate-free placebo (PL) potassium chloride (8 mmol KCl) for a six-day supplementation period.
This pill must be taken on an empty stomach (2-3 hours after eating) and must be taken about 2-3 hours before exercise.
|
This pill must be taken on an empty stomach (2-3 hours after eating) and must be taken about 2-3 hours before exercise.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Muscular Strength
Time Frame: During 1 month of study
|
Muscular Strength will be tested using the isometric and isokinetic strength tests.
|
During 1 month of study
|
|
Muscular Endurance
Time Frame: 1 month
|
Endurance will be tested using the 2000 meter rowing ergometer test and CrossFit circuit known as "Fran".
|
1 month
|
|
Muscular Power
Time Frame: 1 month
|
Power will be measured using the Wingate cycle test.
|
1 month
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Michael Ormsbee, PhD, Florida State University
- Study Director: Samuel J Kramer, BS, Florida State University
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- HSC2014
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Performance
-
Ankara UniversityBurdur Mehmet Akif Ersoy UniversityCompletedAnaerobic Performance Neuromuscular Performance Cognitive PerformanceTurkey (Türkiye)
-
Lindenwood UniversityCompletedExercise Performance | Exercise Performance of Fit Athletes | Cycling PerformanceUnited States
-
Gümüşhane UniversıtyCompletedInspiratory Muscle Training | Jump Performance | Shooting Performance | Precision Sport PerformanceTurkey (Türkiye)
-
Shanghai University of SportRecruitingAthletic Performance | Physical PerformanceChina
-
Atılım UniversityNot yet recruitingCognitive Performance | Physical PerformanceTurkey
-
University of GaziantepCompletedExercise Performance | Physical PerformanceTurkey (Türkiye)
-
Jacksonville State UniversityCompletedCognitive Function | Anaerobic Performance | Resistance Exercise Performance | Dietary Supplementation Athletic PerformanceUnited States
-
Krzysztof MizeraCompletedCognitive Performance | Physical PerformancePoland
-
Federal University of VicosaCompletedAthletic Performance | Sprint Performance | YouthsColombia
-
University of MoliseGiuseppe Calcagno; Giovanni Fiorilli; Andrea Buonsenso; Alessandra di CagnoCompletedAcademic Acheivement | Cognitive Performance | Physical PerformanceItaly
Clinical Trials on Dietary Nitrate
-
Heinrich-Heine University, DuesseldorfCompleted
-
Nanyang Technological UniversityCompletedExercise PerformanceSingapore
-
University of VirginiaCompletedArterial Stiffness | Vascular DilationUnited States
-
Royal College of Surgeons, IrelandUniversity College Dublin; Connolly Hospital BlanchardstownCompletedHypertension
-
Royal College of Surgeons, IrelandUniversity College Dublin; Connolly Hospital BlanchardstownCompletedChronic Obstructive Pulmonary DiseaseIreland
-
Royal College of Surgeons, IrelandUniversity College Dublin; Connolly Hospital BlanchardstownCompletedCardiomyopathy
-
Gladwin, Mark, MDNational Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Failure | Preserved Ejection Fraction | Pulmonary; HypertensionUnited States
-
University Hospital, EssenUnknown
-
Royal College of Surgeons, IrelandUniversity College Dublin; Connolly Hospital BlanchardstownCompletedObstructive Sleep Apnoea SyndromeIreland
-
University of VirginiaRecruitingPeripheral Arterial Disease | Peripheral Vascular DiseasesUnited States